Under construction – not a live service
Sign in

NCT07915895Recruiting

Retroperitoneal Tumor Registry

Retroperitoneal Tumor Registry: A Real-world Cohort Study of Clinical Features, Surgical Outcomes and Long-term Survival

Source: ClinicalTrials.gov · Last updated 4 Nov 2026

Next steps

Brief summary (registry, in English)

This is an observational, real-world registry study. The RETROR registry aims to establish a clinical database for patients with retroperitoneal tumors. We will systematically collect demographic information, comorbidities, preoperative imaging findings, perioperative parameters, pathological outcomes, adjuvant treatment, surgical complications, recurrence, metastasis, and long-term survival data. The registry will summarize clinical features, evaluate surgical outcomes, and explore prognostic factors of retroperitoneal tumors. Written informed consent will be obtained from all participants prior to enrollment.

Status (registry)
Recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
30 Oct 2026
Start date
1 Dec 2024
Primary completion date
1 Dec 2027
Lead sponsor
The First Hospital of Jilin University
NCT number
NCT07915895

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 1 Dec 2024 to the primary completion date, 1 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with psychiatric or neurological disorders who cannot express their will properly.

Other

  • Patients who are unable to understand the study protocol and refuse to participate or sign the informed consent form.

Who the study is looking for

  • Patients with preoperative imaging or pathological diagnosis of retroperitoneal tumors, with no restriction on age and gender.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
The First Hospital of Jilin UniversityChangchunChinaRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.